3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Anti-hyperglycemic effects of Cissus quadrangularis extract via regulation of gluconeogenesis in type 2 diabetic db/db mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: Cissus quadrangularis is a vining plant widely used as a traditional herbal remedy for various ailments. In this study, the therapeutic effects of C. quadrangularis extract (CQR-300) on type 2 diabetes mellitus (T2DM) were investigated in a leptin receptor-mutated db/db mouse model.

          Methods: CQR-300 was orally administered to db/db mice (n = 6/group) at different doses (50, 100, and 200 mg/kg) for 8 weeks. Blood glucose levels and oral glucose tolerance were assessed using the AccuCheck glucometer. Enzyme-linked immunosorbent assay was performed to evaluate insulin and hemoglobin A1c (HbA1c) levels in the blood of db/db mice. Liver and pancreatic tissues from db/db mice were examined by hematoxylin and eosin (H&E) and immunohistochemical staining. The protein levels of gluconeogenesis-, lipogenesis-, and oxidative stress-related factors were evaluated using western blotting.

          Results and discussion: CQR-300 treatment effectively reduced body weight, blood glucose, and insulin levels. HbA1c levels were increased by leptin receptor mutation. Additionally, in the oral glucose tolerance tests, the CQR-300 treated group had a faster blood glucose recovery rate than the db/db group. H&E and Oil red-O staining of the liver showed decreased lipid accumulation in the CQR-300 treated group than the db/db group. Western blot analysis confirmed that CQR-300 effectively inhibited gluconeogenesis, lipogenesis, and oxidative stress-related factors. Our findings suggest that CQR-300 has the potential to be used as a T2DM supplement.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: not found
          • Article: not found
          Is Open Access

          Adipose tissue and insulin resistance in obese

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            NAFLD as a continuum: from obesity to metabolic syndrome and diabetes

            Background The prevalence of non-alcoholic fatty liver disease (NAFLD) has been increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a quarter of global population and regularly coexisting with metabolic disorders such as type 2 diabetes, hypertension, obesity, and cardiovascular disease. In a more simplistic view, NAFLD could be defined as an increase in liver fat content, in the absence of secondary cause of steatosis. In fact, the clinical onset of the disease is a much more complex process, closely related to insulin resistance, limited expandability and dysfunctionality of adipose tissue. A fatty liver is a main driver for a new recognized liver-pancreatic α-cell axis and increased glucagon, contributing to diabetes pathophysiology. Main text This review will focus on the clinical and pathophysiological connections between NAFLD, insulin resistance and type 2 diabetes. We reviewed non-invasive methods and several scoring systems for estimative of steatosis and fibrosis, proposing a multistep process for NAFLD evaluation. We will also discuss treatment options with a more comprehensive view, focusing on the current available therapies for obesity and/or type 2 diabetes that impact each stage of NAFLD. Conclusion The proper understanding of NAFLD spectrum—as a continuum from obesity to metabolic syndrome and diabetes—may contribute to the early identification and for establishment of targeted treatment.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.

              Several studies have explored the impact of nonalcoholic fatty liver disease (NAFLD) on risk of incident type 2 diabetes. However, the extent to which NAFLD may confer risk of incident diabetes remains uncertain. We performed a meta-analysis of relevant studies to quantify the magnitude of the association between NAFLD and risk of incident diabetes.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2569618/overviewRole: Role: Role:
                Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2649220/overviewRole: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2759874/overviewRole: Role: Role: Role: Role:
                Role: Role: Role: Role: Role:
                Role: Role:
                Role:
                URI : https://loop.frontiersin.org/people/2753147/overviewRole: Role:
                URI : https://loop.frontiersin.org/people/2315702/overviewRole: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1588435/overviewRole: Role: Role: Role: Role:
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                10 July 2024
                2024
                : 15
                : 1415670
                Affiliations
                [1] 1 College of Veterinary Medicine (BK21 FOUR Program) , Chungnam National University , Daejeon, Republic of Korea
                [2] 2 Research Institute , NUON Co., Ltd. , Seongnam, Republic of Korea
                [3] 3 EveryH Co., Ltd. , Seoul, Republic of Korea
                Author notes

                Edited by: Muhammad Furqan Akhtar, Riphah International University (Lahore), Pakistan

                Reviewed by: Yuanhao Qiu, Pingdingshan University, China

                Sinisa Djurasevic, University of Belgrade, Serbia

                Abdul Rauf Shakoori, University of the Punjab, Pakistan

                Syed Anees Ahmed, East Carolina University, United States

                *Correspondence: Tae-Won Kim, taewonkim@ 123456cnu.ac.kr ; Je-Won Ko, rheoda@ 123456cnu.ac.kr
                Article
                1415670
                10.3389/fphar.2024.1415670
                11266303
                39050759
                5f0bb39a-e324-48bf-a80e-1c0c58dfbcaa
                Copyright © 2024 Kim, Jeong, Kim, Chung, Kim, Lee, Choi, Lim, Ko and Kim.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 13 April 2024
                : 19 June 2024
                Funding
                The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
                Categories
                Pharmacology
                Original Research
                Custom metadata
                Experimental Pharmacology and Drug Discovery

                Pharmacology & Pharmaceutical medicine
                anti-hyperglycemic effect,cissus quadrangularis,gluconeogenesis,lipogenesis,oxidative stress,type 2 diabetes mellitus

                Comments

                Comment on this article